We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Serum Leptin Concentration Predict Cardiovascular Outcomes in Hemodialysis Patients

By LabMedica International staff writers
Posted on 21 Jun 2021
Print article
Image: The Leptin enzyme-linked immunosorbent assay is for the quantitative determination of leptin in human serum (Photo courtesy of the American Laboratory Products Company)
Image: The Leptin enzyme-linked immunosorbent assay is for the quantitative determination of leptin in human serum (Photo courtesy of the American Laboratory Products Company)
Leptin, a 16-kDa protein product mainly secreted by adipocytes, has been known to increase energy expenditure, suppress appetite, and leads to weight loss. Hyperleptinemia was common in maintenance hemodialysis (MHD) patients, and it was likely to be one of the causes of anorexia and malnutrition.

End-stage renal disease (ESRD) is the fifth stage of chronic kidney diseases (CKD) whose effective treatment includes kidney transplantation and dialysis. Hemodialysis could be one of the optimal choices for ESRD patients to obtain a better prognosis. However, cardiovascular events, malnutrition, infection and other complications were still the major factors affecting the prognosis of MHD patients.

Nephrologists at the West China Hospital of Sichuan University (Chengdu, China) enrolled a total of 165 eligible patients with a mean age of 51(range: 43–65) years, 98 (59.4%) were male and 67 (40.6%) were female, in a prospective study to explore the associations between serum leptin concentration and cardiovascular prognosis in maintenance hemodialysis patients. Serum biochemical parameters were recorded based on the blood samples from a routine checkup, which were collected close to the day that body composition assessment was carried out and measured in a central laboratory.

Blood specimens from patients were obtained before a midweek hemodialysis session and immediately prepared for the subsequent leptin concentration tests. After centrifugation at 3,000 rpm for five minutes, serum was extracted and stored at −80° C. The human leptin ELISA kit (American Laboratory Products Company, ALPCO, Salem, NH, USA) was used to measure the serum leptin concentration in duplicate. The detection limit was 0.1 ng/mL. The intra-assay and inter-assay variation were < 3.5% and < 6.4%, which suggested the test method was reliable.

The scientists reported that the mean serum leptin concentration was 35.49 ± 29.98 ng/mL and patients were divided into two groups of serum leptin concentration ≥ 15.31 ng/mL and serum leptin concentration < 15.31 ng/mL by the optimal cut-off point from ROC curve for cardiovascular events (CVEs). During a median follow-up of 18 (12–22) months, CVEs occurred in 37 (22.4%) patients and the cardiovascular and all-cause mortality was 10.9% and 21.82%. Serum leptin concentration was associated with CVEs (hazard ratio [HR] = 0.982), cardiovascular death (CVD) (HR = 0.934) and all-cause death (HR = 0.943). Decreased serum leptin concentration was an independent risk factor for the development of left ventricular hypertrophy (LVH, odds ratio [OR] = 0.98) and peripheral vascular disease (PVD, OR = 0.974).

The authors concluded that serum leptin concentration can independently predict cardiovascular outcomes and all-cause death in MHD patients. They suggest that the effects that serum leptin concentration has on development of LVH and PVD maybe the potential mechanism. The study was published on June 4, 2021 in the journal Clinica Chimica Acta.

Related Links:
West China Hospital of Sichuan University
American Laboratory Products Company


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.